Yale PET Center received $102 million BRAIN Initiative grant to build new scanner
On Oct. 2, 2020, Yale scientists announced construction of the next-generation human brain PET scanner, the NeuroeXplorer (NX),…
WHO welcomed $90 million contribution from Kingdom of Saudi Arabia to support COVID-19 global response
On Oct. 2, 2020, the WHO and the Kingdom of Saudi Arabia signed a contribution agreement in the…
Quidel received Emergency Authorization for rapid antigen ‘ABC test’ assay for Influenza A+B and COVID-19
On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…
Humanigen announced COVID-19 case report demonstrated rapid resolution after single IND EUA of Lenzilumabﾙ
On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabﾙ in critical…
UConn funded five COVID-19 research projects, announced additional funding
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) (OVPR) announced a new…
LabCorp COVID-19 molecular test innovation received FDA authorization
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the FDA…
19 organizations from the healthcare community unite to form COVID-19 testing industry consortium
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
Veklury (remdesivir) made available directly from distributor
On Oct. 1, 2020, american hospitals began purchasing Veklury (remdesivir) directly from the drugﾒs distributor. Veklury is an…
Gilead Sciences updated supply and distribution of Vekluryﾮ (remdesivir) in the US
On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….
Amyris delivered sustainable alternative to shark squalene adjuvant enabling vaccines with no sharks killed
On Oct. 1, 2020, Amyris announced that it has begun delivering samples to pharmaceutical companies of a sustainable…
Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billion
On Oct. 1, 2020, Johnson & Johnson announced it had successfully completed its acquisition of Momenta Pharmaceuticals, a…
Neandertal gene variant increases risk of severe Covid-19
On Sept. 30, 2020, researchers at the Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary…
NIH assessed and expanded COVID-19 testing for underserved communities
On Sept. 30, 2020, the NIH announced that it had awarded nearly $234 million to improve COVID-19 testing…
Oxford researchers started new trial on the use of anti-TNF to treat Covid-19 in care homes
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
National Science Foundation funded more than 80 startups to address COVID-19 challenges
On Sept. 30, 2020, the National Science Foundation (NSF) announced that it had funded more than 80 startups…
NIH funded first nationwide network to study rare forms of diabetes
On Sept. 30, 2020, the NIH announced funding of a nationwide study to discover the cause of several…
WHO welcomed nearly $1 billion in pledges to bolster access to tests, treatments and vaccines to end COVID-19
On Sept. 30, 2020, the United Nations and its partners announced that nearly $1 billion in financing was…
Sorrento Therapeutics and ViralClear entered agreement to explore combination antibody plus antiviral therapy against COVID-19
On Sept. 30, 2020, ViralClear Pharmaceuticals and Sorrento Therapeutics announced the companies were exploring the synergistic potential of…
Bio-Techne announced opening of GMP manufacturing facility in Twin Cities
On Sept. 30, 2020, Bio-Techne announced the opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing…
Quest Diagnostics launched three new combined COVID-19 and respiratory virus tests
On Sept. 30, 2020, Quest Diagnostics announced three different test options for healthcare providers across the U.S.to aid…
BD announced CE Mark of portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes
On Sept. 30, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
BioNTech and Pfizer announced Nature publication of German phase 1/2 study data from mRNA-based vaccine candidate against SARS-CoV-2
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
Hydroxychloroquine showed no benefit in COVID-19 prevention
On Sept. 30, 2020, researchers from the Perelman School of Medicine at the University of Pennsylvania reported results…
Investigational COVID-19 vaccine well tolerated and generated iImmune response in older adults
On Sept. 29, 2020, the National Institute of Allergy and Infectious Diseases announced that a phase 1 trial…
CureVac Initiated phase 2a clinical trial of COVID-19 vaccine candidate
On Sept. 29, 2020, CureVac announced that the first participant has been dosed in a Phase 2a clinical…
Increased COVID-19 cases reported in US among adults aged 18ﾖ22 years
On Sept. 29, 2020, the CDC reported that during Aug. 2ﾖSept. 5, 2020, weekly COVID-19 cases among persons…
Computer-designed proteins may protect against coronavirus
On Sept. 29, 2020, the NIH announed that researchers had designed ﾓminiproteinsﾔ that bound tightly to the SARS-CoV-2…
Oxford Immunotec announced FDA clearance of the T-SPOT.TB test for use in pediatrics over the age of two
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the FDA to amend the…
Serum Institute to produce additional 100 million Covid-19 vaccine doses for India and low-and middle-income countries
On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…
New look at COVID-19 cases does not support link between BCG vaccination and lower mortality
On Sept. 29, 2020, In a new Letter, published in PNAS, researchers at La Jolla Institute for Immunology…